SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-016003
Filing Date
2024-05-10
Accepted
2024-05-10 16:06:40
Documents
5
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A aytu20240409_def14a.htm DEF 14A 573831
2 aytuproxy01.jpg GRAPHIC 259420
3 aytuproxy02.jpg GRAPHIC 179711
4 netloss2.jpg GRAPHIC 206704
5 tsr.jpg GRAPHIC 207386
  Complete submission text file 0001437749-24-016003.txt   1750129
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-38247 | Film No.: 24934846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)